Institutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant

Transcription

1 Relationships With Industry and Other Entities (Comprehensive) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (August 2018) Institutional,, or Other Financial Ownership/ Representation Employment Consultant Speakers Bureau Partnership/Principa l Personal Research Benefit Expert Witness Salary Yong-Mei Cha Zachary D. Goldberger Richard J. Kovacs Kevin F. Kwaku Daniel M. Philbin Jr Peter A. Brady AHA ACC Science and Quality Committee AHA ACC Board of Governors HRS Mayo Clinic, Diseases Washington School of Assistant, Harborview Center Indiana University School of, Krannert Institute of Clinical Dartmouth- Hitchcock New England Heart Institute Mayo Clinic, Mayo Foundation Biomedical Systems* Jazz Pharmaceuticals Theravance, Inc. Armaron Pharmaceuticals Eli Lilly and Company (DSMB)* NIH Siemens MED Institute* Medtronic High Energy* St. Jude Abbott Boston Scientific

2 Ratika Parkash Jonathan Philpott Kevin Shannon Gus J. Vlahakes Nazem Akoum Sana M. Al- Khatib HRS STS PACES AATS Dalhousie University and Nova Scotia Health Authority, (Arrhythmia); Director of Research, Mid-Atlantic Cardiothoracic Surgeons Mattel Children's Hospital at UCLA Clinical Professor, Pediatric Harvard School and Massachusetts General Hospital Surgery Washington Duke Clinical Research Institute Bayer* Medtronic Pfizer* St. Jude * AtriCure* LifeNet Health Amgen Defendant, Cardiac arrest during Amiodarone administration, 2017* AHRQ* FDA* PCORI* VA Health System (DSMB) Elsevier* NHLBI Third party, ICDs, 2017 Third party, ICD implantation, 2018

3 Joshua A. Beckman Kim K. Birtcher Mitchell I. Cohen Freddy Del- Carpio Munoz Bernard Dennis Anita Deswal Andrew E. Epstein PACES ERC Member ACC/AHA Lay Vanderbilt University Center Director, Section of Vascular Houston College of Pharmacy Clinical Professor Antidote Pharmaceuticals AstraZeneca* Bristol Myers Squibb* Janssen Pharmaceuticals Sanofi Jones & Bartlett Learning EMX JanaCare Bayer (DSMB)* Novartis (DSMB) Vascular Interventional Advances* Accreditation Council for Clinical Lipidology Pediatric Associates Mayo Clinic Dennis Associates, LLC Michael E. DeBakey VA Center Chief, ; Baylor College of The Hospital of the Pennsylvania PeerView Institute of Learning* NIH* AHA Committee on HF and Transplantation AHA Get with the Steering Committee HFSA KDIGO NIH Novartis ZOLL Biotronik* Boston Scientific* Boston Scientific (DSMB)* Medtronic* Medtronic (DSMB) St Jude /Abbott* St. Jude /Abbott (DSMB)* Defendant, Appropriateness of Monitoring, 2017 University of Houston College of Pharmacy*

4 Michael E. Field Michael S. Firstenberg John D. Fisher Federico Gentile Anne M. Gillis Bulent Gorenek ACC Surgeons Member Section and Leadership Council ACC Electrophysiolo gy Member Section Chair Wisconsin School of and Public Health Director, Clinical Electrophysiolog y and Cardiac Arrhythmia Service The Center of Aurora Chair, and Cardiothoracic Surgery Montefiore Center Program Director CCEP Centro Cardiologico Gentile Calgary Eskisehir Osmangazi University Department AllMed* Grifols Johnson & Johnson/Ethicon * Maquet * Medtronic Medtronic* Biotronik* Biotronik Boston Scientific/Guidant * Boston Scientific Medtronic* Medtronic St. Jude * St. Jude AHA Medtronic* Libin Institute of Alberta Bayer Boehringer Ingelheim Daiichi-Sankyo Pfizer

5 Mohamed H. Hamdan Glenn N. Levine Mark S. Link Daniel L. Lustgarten Siva K. Mulpuru Patrick T. O'Gara Brian Olshansky David S. Park ERC Member AHA Wisconsin- Madison Chief of Baylor College of Michael E. DeBakey Center Director, Cardiac Care Unit UT Southwestern Center Vermont School of Mayo Clinic Associate Professor Harvard School Brigham and Women's Hospital Director, Strategic Planning NYU Langone Health Assistant Professor, Department of ClinicNotes, LLC F2 Solutions, Inc Wisconsin- Madison* Defendant, Out of hospital cardiopulmonar y arrest, 2017* Defendant, Out of hospital death, 2018* NEJM Group TIMI Study Group* UpToDate* Journal Watch Abbott/St. Jude Biotronik Boston Scientific Medtronic* Medtronic (DSMB)* Gilead Sciences, Inc. Biotronik Medtronic Mayo Clinic Edwards Scientific Medtronic NIH* Boehringer Amarin (DSMB)* Ingelheim Lundbeck Inc.* Circulation *

6 Mariann Piano Merritt H. Raitt Satish R. Raj Win-Kuang Shen David J. Slotwiner ERC Vice Chair ERC Chair Vanderbilt University School of Nursing Nancy and Hilliard Travis Nursing; Senior Associate Dean for Research Oregon Heath & Science University; VA Portland Health Care System Cardiologist Calgary Mayo Clinic Arizona, Phoenix Campus Chair, Department of Diseases Weill Cornell College Chief, ; Assistant Clinical NIH Allergan Inc GE Healthcare* Lundbeck Inc. Canadian Institutes of Health Research* Cardiac Arrhythmia Network of Canada (CANet)* American Autonomic Society Association of Clinical and Translational Research Dysautonomia International

7 Cynthia M. Tracy Richard G. Trohman Gaurav A. Upadhyay ACC Electrophysiolo gy Member Section The George Washington University School of & Health Sciences Associate Director of Rush University Center The Chicago Assistant Director, Heart Station NIH Cheney Institute Daiichi Sankyo* HRS Sorin Group Rush University Center Biosense Webster Biotronik Boston Scientific Medtronic ZOLL Biotronik* Medtronic* Biosense Webster Biotronik Boehringer Ingelheim Boston Scientific Brady Diagnostics The Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology* Medtronic Pfizer Schwarzer Cardiotek Sorin St. Jude Stereotaxis Chicago Michigan Rochester VG Bio This table represents all relationships of reviewers with industry and other entities that were reported at the time of peer review, including those not deemed to be relevant to this document, at the time this document was under review. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% of the voting stock or share of the business entity, or ownership of $5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest

8 unless otherwise noted. Names are listed in alphabetical order within each category of review. Please refer to for definitions of disclosure categories or additional information about the ACC/AHA Disclosure Policy for Writing Committees. *Significant relationship. No financial benefit. This disclosure was entered under the Clinical Trial Enroller category in the ACC s disclosure system. To appear in this category, the author acknowledges that there is no direct or institutional relationship with the trial sponsor as defined in the ACC/AHA Disclosure Policy for Writing Committees. AATS indicates American Association for Thoracic Surgery; ACC, American College of ; AHA, American Heart Association; AHRQ, Agency for Healthcare Research and Quality; CCEP, Clinical Cardiac Electrophysiology; DSMB, data safety monitoring board; ERC, evidence review committee; FDA, U.S. Food and Drug Administration; GE, General Electric; HF, heart failure; HFSA, Heart Failure Society of America; HRS, Heart Rhythm Society; ICD, Implantable Cardioverter Defibrillator; KDIGO, Kidney Disease Improving Global Outcomes; LLC, limited liability company, NEJM, New England Journal of NHLBI, National Heart, Lung, and Blood Institute; NIH, National Institutes of Health; NYU, Ney York University; PACES, Pediatric & Congenital Electrophysiology Society; PCORI, Patient-Centered Outcomes Research Institute; STS, the Society of Thoracic Surgeons; TIMI, Thrombolysis in Myocardial Infarction; UCLA, California, Los Angeles; UT, Texas; and VA, Veterans Affairs.